Who invested in CureGenetics

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$26Mraised across 2 rounds since 2018, from 2 sources

$17MSeries A$9.0MSeries B

Latest round: Series B, $9.0MMar 2024
Biggest round: $17MSeries A · Aug 2018
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201920202021202220232024

$17MSeries A$9.0MSeries B

First round: Series A, $17M
Biggest round: $17M
Between rounds: 5.6 years

The rounds

Mar 2024
Series B$9.0M3 new
Source recorded
Aug 2018
Series A$17M2 new
- Ascendin
- Qiming Venture Partners/ CTS
Reported by FinSMEs

Founders and team

From CureGenetics's own website: 1 founder, 3 on the team.

Dr. Yanni LinCo-founder & Chief Scientist

Dr. Yuanyuan XuChairman & CEO
Dr. Shawn HeChief Scientific Officer
Grace HeSVP，Head of Clinical Development

AdvisersDr. Zihe Rao

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2018Series B2024

Qiming Venture Partners

Oriza HoldingsQingsong FundAscendinQiming Venture Partners/ CTS

Everyone who backed them

Qiming Venture PartnersVC firm1round

Oriza HoldingsVC firm1round

Qingsong FundVC firm1round

Ascendinno record of our own yet1round

Qiming Venture Partners/ CTSno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about CureGenetics